Comments

Aclaris Therapeutics Stock Price, Quotes and Forecasts

Q: What sector and industry does Aclaris Therapeutics (ACRS) operate in?

Aclaris Therapeutics is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.

ACRSNASDAQ

Logo brought to you by Benzinga Data

Perks Buy Compare Brokers

$1.73

0.031.88%

After Hours: 9:22 AM EDT

Aclaris Therapeutics (ACRS) Forecast

News Earnings Aclaris Therapeutics (ACRS) Options Guidance Dividends Analyst Ratings Insider Trades Short Interest

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Aclaris Therapeutics Stock Price, Quotes and Forecasts | NASDAQ:ACRS | Benzinga

Explore Aclaris Therapeutics stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for ACRS.

Open	$1.68
Close	-
Volume / Avg.	778.62K / 908.96K
Day Range	$1.66 - $1.78
52 Wk Range	0.95 - 5.17
Market Cap	$179.26M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	37
Short Interest	4.99%
Days to Cover	8.44

Recent News

Aclaris Stock Rises As Analyst Projects Billions In Sales For New Therapy

HC Wainwright upgraded Aclaris Therapeutics (ACRS) to Buy with a $20 price target. Aclaris gains after licensing agreement with Biosion for potential best-in-class therapies for atopic dermatitis and asthma.

Anusuya Lahiri

This Weyerhaeuser Analyst Turns Bullish; Here Are Top 4 Upgrades For Monday

Avi Kapoor

Aclaris Stock Soars As Analysts See Fresh Momentum After Strategic Review And Encouraging Promising Pipeline Developments

Aclaris secures global rights to Biosion's BSI-045B, advancing trials for atopic dermatitis, asthma, and more. Stock surges on promising updates.

Vandana Singh

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trends and Forecast

Nov 24

Dec 24

Mar

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

3.7

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Open	$1.68
Close	-
Volume / Avg.	778.62K / 908.96K
Day Range	$1.66 - $1.78
52 Wk Range	0.95 - 5.17
Market Cap	$179.26M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	37
Short Interest	4.99%
Days to Cover	8.44

About Aclaris Therapeutics Inc

Sector

Health Care

Industry

Pharmaceuticals

Aclaris Therapeutics Inc is a clinical-stage biopharmaceutical company that operates in the United S...

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Aclaris Therapeutics (ACRS) stock?

You can purchase shares of Aclaris Therapeutics (NASDAQ:ACRS) through any online brokerage.

View our list of the best stock brokerages

Who are Aclaris Therapeutics (ACRS) competitors?

Other companies in Aclaris Therapeutics’s space includes: Atea Pharmaceuticals (NASDAQ:AVIR), Third Harmonic Bio (NASDAQ:THRD), Bioage Labs (NASDAQ:BIOA), Terns Pharma (NASDAQ:TERN) and Neumora Therapeutics (NASDAQ:NMRA).

What is the forecast, or price target, for Aclaris Therapeutics (ACRS) stock?

Aclaris Therapeutics has a consensus price target of $12.67.

What is the current price for Aclaris Therapeutics (ACRS)?

The stock price for Aclaris Therapeutics (NASDAQ: ACRS) is $1.675 last updated March 25, 2025 at 3:47 PM EDT.

Does Aclaris Therapeutics (ACRS) pay a dividend?

There are no upcoming dividends for Aclaris Therapeutics.

When is Aclaris Therapeutics (NASDAQ:ACRS) reporting earnings?

Aclaris Therapeutics’s Q1 earnings are confirmed for Tuesday, May 6, 2025.

Is Aclaris Therapeutics (ACRS) going to split?

There is no upcoming split for Aclaris Therapeutics.

What sector and industry does Aclaris Therapeutics (ACRS) operate in?

Aclaris Therapeutics is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.